Amoxycillin resistance is one reason for failure of amoxycillin-omeprazole treatment of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 12, Issue 7, 1998, Pages 635-639

  Dore, M P ^a,c,d   Piana, A ^a   Carta, M ^a   Atzei, A ^a   Are, B M ^a   Mura, I ^a   Massarelli, G ^b   Maida, A ^a   Sepulveda, A R ^c   Graham, D Y ^c   Realdi, G ^a  

^a Università Degli Studi di Sabari   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; OMEPRAZOLE; UREASE;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DYSPEPSIA; ENZYME ASSAY; FEMALE; HELICOBACTER PYLORI; HISTOLOGY; HUMAN; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; PATIENT COMPLIANCE; PRIORITY JOURNAL; QUESTIONNAIRE; SMOKING HABIT; STOMACH BIOPSY;

ADULT; AGED; AMOXICILLIN; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; OMEPRAZOLE; PATIENT COMPLIANCE; PENICILLIN RESISTANCE; PENICILLINS; PROSPECTIVE STUDIES; QUESTIONNAIRES;

EID: 7344243776     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1998.00350.x     Document Type: Article

References (23)

1. Walsh JH, Peterson WL. The treatment of Helicobacter pylori infection in the management of peptic ulcer disease. N Engj J Med 1995; 333: 984-991.
2. Graham DY, Go MF. Helicobacter pylori: current status. Gastroenterology 1993; 105: 279-82.
3. National Institutes of Health. Consensus conference: Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
4. van de Hulst RWM, Keller JJ, Rauws EAJ, Tytgat GNJ. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1996; 1: 6-19.
5. Penston JG, McColl KEL. Eradication of Helicobacter pylori: an objective assessment of current therapies. Br J Clin Pharmacol 1997; 43: 223-43.
6. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
7. Tytgat GNJ. Review article: treatments that impact favourably upon the eradication of Helicobacter pylori and ulcer recurrence. Aliment Pharmacol Ther 1994; 8: 359-68.
8. Bayerdorffer E, Mannes GA, Sommer A, et al. Long-term follow-up after eradication of Helicobacter pylori with a combination of omeprazole and amoxycillin. Scand J Gastroenterol 1993; 196(Suppl. 28): 19-25.
9. Labenz J, Gyenes E, Ruhl GH, Borsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 88: 491-5.
10. Dore MP, Sepulveda AR, Mura I, Realdi G, Osato MS, Graham DY. Explanation for variability of omeprazole amoxicillin therapy? Tolerance of H. pylori to amoxicillin. Gastroenterology 1997; 112: A105(Abstract).
11. Fedorak R, Archambault A, Flamm R, Osato M, Stamler D. Antimicrobial susceptibility of H. pylori in Canada to three key antibiotics: metronidazole, clarithromycin, and amoxicillin. Gastroenterology 1997; 112: A115(Abstract).
12. Misiewic JJ, Tytgat GNJ, Goodwin CS, et al. The Sidney System: a new classification of gastritis. J Hepatol Gastroenterol 1991; 6: 209-22.
13. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically: approved standards. NCCLS publication M7-A3. Villanova. PA: NCCLS. 1997.
14. SAS Institute. Inc. SAS user's guide: Statistics, version 5 ed. Cary. NC: SAS Institute. Inc., 1985.
15. Piana A, Dore MP, Carta M, et al. Characterization of chromosomal DNA profiles from Helicobacter pylori strains: comparison between methods. Ital J Gastroenterol Hepatol 1997; 29(Suppl. 2): A60(Abstract).
16. Labenz J, Gyenes A, Ruhl GH, Borsch G. Omeprazole plus amoxicillin: efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993; 4: 491-5.
17. Adamek RJ, Wegener M, Labenz J, Freitag M, Opferkuch W, Rhul GH. Medium-term results of oral and intravenous omeprazole/amoxicillin Helicobacter pylori eradication therapy. Am J Gastroenterol 1994; 89: 39-42.
18. Bayerdoffer E, Miehlke S, Mannes G, et al. Double-blind trial of omeprazole and amoxicillin to cure Helicobacter pylori infection in patients with duodenal ulcers. Gastroenterology 1995; 108: 1412-17.
19. Graham KS, Malaty H, El-Zimaity HMT, et al. Variability with omeprazole-amoxicillin combinations for treatment of Helicobacter pylori infection. Am J Gastroenterol 1995; 90: 1415-18.
20. Unge P. Review of Helicobacter pylori eradication regimens. Scand J Gastroenterol 1996; (Suppl. 215): 74-81.
21. Hirschl A, Rotter ML. Amoxicillin for the treatment of Helicobacter pylori infection. J Gastroenterol 1996; 31(Suppl. 9): 44-7.
22. Labenz J, Leverkus F, Borsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection. Factors influencing the treatment success. Scand J Gastroenterol 1994; 29: 1070-5.
23. Goessens WHF, Fontijne P, Van Raffe M, Michel MF. Tolerance percentage as a criterion for the detection of tolerant Staphylococcus aureus strains. Antimicrob Agents Chemother 1984; 25: 575-8.